European Archives - Page 457 of 1138 - European Medical Journal

EMJ Respiratory 10 [Supplement 1] 2022

All human diseases, including COPD, are the end result of gene–environment interactions. However, this conventional model is being modified. COVID-19 demonstrated that mortality is higher in older versus younger individuals. The viral and environmental exposures were the same, but the obvious difference was age.

Creating winning pharma communications

Silvia Taylor, Executive Vice President and Chief Communications Officer, Novavax, discusses her passion for engaging the world in the wonder of science.

Infographic: Systemic mastocytosis (SM) is a rare form of mast cell disorder characterised by abnormal proliferation and activation of mast cells

Systemic Mastocytosis Disease Awareness Infographic: Learn more about this rare disease, its prevelance, symptoms, sub-types and diagnosis.

Review of the United European Gastroenterology (UEG) Week 2022

‘INGEST the best’ was the theme for the 30th anniversary of the United European Gastroenterology (UEG) Week, which took place in Vienna, Austria, and virtually on 8th–11th October 2022.

Clinical Effectiveness of Gluten Immunogenic Peptides During Follow-Up of Coeliac Disease

This is an observational, retrospective, longitudinal, between-groups study design. The authors collected clinical data from patients who had GIP measurement during follow-up from January 2017–June 2021. A descriptive and comparative analysis was performed using SPSS software (IBM, Armonk, New York, USA). The primary objective was to evaluate the clinical effectiveness of GIP measurement during follow-up of patients with coeliac disease. The secondary objective was to analyse the relation between GIP levels and demographic data (gender and age), laboratory results, and histopathology.

EMJ Gastroenterology 11.1 2022

Welcome to the latest issue of EMJ Gastroenterology, which outlines key advances in the field. Featured articles include a case report on medullary carcinoma of the pancreas and a review of the challenges in inflammatory bowel disease management during the COVID-19 pandemic in resource-limited settings. Our independent review of United European Gastroenterology (UEG) Week 2022 is also not to be missed!

Demographic and Clinical Presentation of Hospitalised Patients with SARS-CoV-2 Omicron Variant

Since the detection of the first cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant causing COVID-19 infections in South Africa in November 2021, there have been a few population-based reports to suggest that the clinical severity and presentation of this variant is different to previous COVID-19 surges.

Challenges and Opportunities for Treating Clostridium difficile in 2022

IN A symposium session presented at United European Gastroenterology (UEG) Week 2022, experts delved into the challenges presented by…

Anxiety, Depression, and Quality of Life in Patients with Functional Dyspepsia: A Cross-Sectional Study

Functional gastrointestinal disorders are often associated with changes in the psycho-emotional sphere. The urgency of the problem is determined by the fact that functional diseases mainly affect young people of working age. This makes the problem not only medical but also social. The aims of this study were to evaluate the clinical characteristics of anxiety and depression in different subtypes of functional dyspepsia (FD) group in comparison to a control group and to establish the presence of a possible correlation between anxiety/depression and quality of life (QoL).

Barrett’s Oesophagus Surveillance: Can We Do Better?

Barrett’s oesophagus (BO) has a premalignant potential. Several guidelines to optimise surveillance and early detection of dysplasia were produced.1-3 A previous audit in the authors’ hospital revealed significant departure from the guidelines.